The use of fermentation in food and beverage preparations, as a means to provide palatability, nutritive value, preservative, and medicinal properties, is an ancient practice. The enhanced nutritional and functional properties of fermented foods may be due to transformation of food molecules and the resulting formation of bioactive or bioavailable end-products. A more recent consideration that intersects with this traditional type of remedy is that of Gastroesophageal Reflux Disease (GERD).
GERD is a modern-day common ailment which is growing in incidence with a global prevalence between 10%-20%, and even higher in westernized countries. Current remedies include synthetic pharmaceutical drugs and invasive surgery. There is a need for plant-based, effective options to address this burgeoning problem without the side effects of more radical solutions. Gastro-AD® is a food supplement based on non-GMO soy fermented by Lactobacillus strain L. delbrueckii R-187 (Rosell-187). It has an excellent track record of safe and effective use for management of symptoms of GERD including heartburn, gastric pain, vomiting, and nausea and has been backed by several published studies, in a total of 600 patients.
Gastro-AD® represents an authentic, safe and proven alternative to over-the-counter (OTC) remedies with the extra nutritional benefits of fermented soy. A current clinical trial is underway, with results expected in mid-2019.
You can learn more about Lallemand’s Gastro-Ad here.
For additional information, please contact us.